Affordable Access

deepdyve-link
Publisher Website

Phase II drugs currently being investigated for the treatment of hypogonadism.

Authors
  • Udedibia, Emeka
  • Kaminetsky, Jed
Type
Published Article
Journal
Expert Opinion on Investigational Drugs
Publisher
Informa UK (Taylor & Francis)
Publication Date
December 2014
Volume
23
Issue
12
Pages
1605–1618
Identifiers
DOI: 10.1517/13543784.2014.948151
PMID: 25113658
Source
Medline
Keywords
License
Unknown

Abstract

With several new therapies in development, the authors expect advancements in achieving treatment benchmarks that meet the needs of the individual symptomatic hypogonadal male. Increased public awareness of hypogonadism and TRT has led to a welcomed expansion in the choice of TRT options. These include new delivery systems, formulations, routes of administration and non-testosterone modalities.

Report this publication

Statistics

Seen <100 times